Correlation Between Sellas Life and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sellas Life and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sellas Life and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sellas Life Sciences and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Sellas Life and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sellas Life with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sellas Life and Tarsus Pharmaceuticals.
Diversification Opportunities for Sellas Life and Tarsus Pharmaceuticals
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sellas and Tarsus is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Sellas Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sellas Life Sciences are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Sellas Life i.e., Sellas Life and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sellas Life and Tarsus Pharmaceuticals
Considering the 90-day investment horizon Sellas Life Sciences is expected to under-perform the Tarsus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Sellas Life Sciences is 1.09 times less risky than Tarsus Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Tarsus Pharmaceuticals is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest 3,967 in Tarsus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 857.00 from holding Tarsus Pharmaceuticals or generate 21.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sellas Life Sciences vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Sellas Life Sciences |
| Tarsus Pharmaceuticals |
Sellas Life and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sellas Life and Tarsus Pharmaceuticals
The main advantage of trading using opposite Sellas Life and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sellas Life position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Sellas Life vs. Eliem Therapeutics | Sellas Life vs. HCW Biologics | Sellas Life vs. Scpharmaceuticals | Sellas Life vs. Milestone Pharmaceuticals |
| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stocks Directory Find actively traded stocks across global markets |